Correlation Engine 2.0
Clear Search sequence regions


  • humans (1)
  • metformin (4)
  • patients (1)
  • therapies (2)
  • Sizes of these terms reflect their relevance to your search.

    Metformin along with other antidiabetic medications provide benefit to patients in the treatment of type 2 diabetes mellitus, but caution is advised in certain scenarios to avoid toxicity in kidney disease. Renal dosing, monitoring of kidney function, and evaluating the risk of developing serious side effects are warranted with some agents. The available literature with regard to incidence of adverse events and toxicity of hypoglycemic therapies is reviewed. Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

    Citation

    Muhammad S Akhter, Priyasha Uppal. Toxicity of Metformin and Hypoglycemic Therapies. Advances in chronic kidney disease. 2020 Jan;27(1):18-30

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32146997

    View Full Text